SCHEMBL21844908

SCHEMBL21844908

Cc1ccc(NC(=O)c2cccc(CCN(CCO)C3CC3)c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 1/20 0.48
▸ TP53 P04637 5/20 0.46
▸ SMN1; SMN2 Q16637 4/20 0.46
▸ NPC1 O15118 4/20 0.46
▸ RAB9A P51151 4/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ TSHR P16473 1/20 0.46
▸ NFKB1 P19838 1/20 0.46
▸ NFKB2 Q00653 1/20 0.46
▸ RELA Q04206 1/20 0.46
▸ MAPT P10636 3/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ FFAR1 O14842 1/20 0.44
▸ GLA P06280 1/20 0.44
▸ CCR2 P41597 2/20 0.43
▸ CTDSP1 Q9GZU7 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ THRB P10828 1/20 0.40
▸ OPRM1 P35372 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20084043 0.90 SMN1; SMN2 (0.47) TP53SMN1; SMN2NPC1RAB9AMAPT
SCHEMBL21844909 0.85 KMT2A (0.40) KDM1ANPC1RAB9AMEN1KMT2A
SCHEMBL20084044 0.83 MAOB (0.44) KDM1ASMN1; SMN2NPC1RAB9AMAPT
SCHEMBL21844906 0.81 BCHE (0.49) KDM1ATP53SMN1; SMN2NPC1RAB9A
SCHEMBL1696476 0.76 NPC1 (0.58) KDM1ATP53SMN1; SMN2NPC1RAB9A
SCHEMBL21844860 0.76 SMN1; SMN2 (0.58) SMN1; SMN2NPC1RAB9AKDM4ETSHR
SCHEMBL19157637 0.74 NPC1 (0.50) TP53SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL15676754 0.74 NPC1 (0.61) KDM1ATP53SMN1; SMN2NPC1RAB9A
SCHEMBL21844862 0.73 MEN1 (0.59) TP53SMN1; SMN2RAB9AKDM4ETSHR
SCHEMBL17664548 0.72 NPC1 (0.59) KDM1ATP53SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3312160-B1 HEPATITIS B ANTIVIRAL AGENTS NOVIRA THERAPEUTICS INC (US) 2020-03-18 — — EP disclosed
Send feedback